MedPath

Patient Experience Data in Radiation Oncology

Recruiting
Conditions
PROMs
Radiotherapy Side Effect
Registration Number
NCT05224297
Lead Sponsor
Medical University of Vienna
Brief Summary

The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or changes in treatment protocols. The pseudonymized data will be linked to data in the oncological information system and dosimetric data from the treatment planning system. In this way, they represent a basic building block of patient-oriented development of clinical radiotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
6000
Inclusion Criteria
  • all patients receiving external beam radiotherapy
Exclusion Criteria
  • unable to independently answer questionnaires on radiation-induced side effects

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
radiation-related side effectsduring radiotherapy and after (up until 5 years)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of Vienna

🇦🇹

Vienna, Austria

Medical University of Vienna
🇦🇹Vienna, Austria
Gerd Heilemann, PhD
Contact
Andreas Renner, PhD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.